Cargando…

Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders

Detalles Bibliográficos
Autores principales:	Vorobyeva, Nataliya, Kozlova, Alena A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089300/ https://www.ncbi.nlm.nih.gov/pubmed/37056991 http://dx.doi.org/10.3389/fphar.2023.1184726

Ejemplares similares

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
por: Vorobyeva, Nataliya, et al.
Publicado: (2022)

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
por: Markopoulos, Athanasios, et al.
Publicado: (2022)

Unifying Theories of Psychedelic Drug Effects
por: Swanson, Link R.
Publicado: (2018)

Bedside to bench: the outlook for psychedelic research
por: Acero, Victor P., et al.
Publicado: (2023)

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
por: Kettner, H., et al.
Publicado: (2021)

Predicting Responses to Psychedelics: A Prospective Study
por: Haijen, Eline C. H. M., et al.
Publicado: (2018)

Amazonian Medicine and the Psychedelic Revival: Considering the “Dieta”
por: O’Shaughnessy, David M., et al.
Publicado: (2021)

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
por: Roseman, Leor, et al.
Publicado: (2022)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)

The possible place for psychedelics in pharmacotherapy of mental disorders
por: Wojtas, Adam
Publicado: (2023)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Corrigendum: Psychedelics as a Treatment for Alzheimer's Disease Dementia
por: Vann Jones, Simon Andrew, et al.
Publicado: (2020)

The association between naturalistic use of psychedelics and co-occurring substance use disorders
por: Rabinowitz, Jonina, et al.
Publicado: (2023)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
por: Schindler, Emmanuelle A. D., et al.
Publicado: (2018)

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
por: Schenberg, Eduardo Ekman
Publicado: (2018)

Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs
por: Tagliazucchi, Enzo
Publicado: (2022)

Psychedelics and Mental Health: A Population Study
por: Krebs, Teri S., et al.
Publicado: (2013)

Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis
por: Basedow, Lukas A., et al.
Publicado: (2021)

Psychedelics as a treatment for disorders of consciousness
por: Scott, Gregory, et al.
Publicado: (2019)

The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health
por: Gandy, Sam, et al.
Publicado: (2020)

The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions
por: Nielson, Elizabeth M., et al.
Publicado: (2018)

Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection
por: Ayatollahi, Seyed Abdulmajid, et al.
Publicado: (2021)

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe
por: Miliano, Cristina, et al.
Publicado: (2019)

The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology
por: Winkelman, Michael James
Publicado: (2021)

The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies
por: Castelhano, João, et al.
Publicado: (2021)

Psychedelic crossings: American mental health and LSD in the 1970s
por: Richert, Lucas, et al.
Publicado: (2020)

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience
por: Gallimore, Andrew R., et al.
Publicado: (2016)

Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG
por: Chen, Yahong, et al.
Publicado: (2023)

Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives
por: Tan, Hui-Li, et al.
Publicado: (2016)

Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1
por: Mühlhaus, Jessica, et al.
Publicado: (2017)

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
por: dos Santos, Thaiane Coelho, et al.
Publicado: (2018)

Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes
por: Matzopoulos, Richard, et al.
Publicado: (2022)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health
por: Ryan, Rebecca S., et al.
Publicado: (2023)

Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process
por: Inserra, Antonio
Publicado: (2018)

The Natural Polypeptides as Significant Elastase Inhibitors
por: Ahmad, Shabir, et al.
Publicado: (2020)

Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study
por: Akasov, R. A., et al.
Publicado: (2022)

Psychedelics and Other Psychoplastogens for Treating Mental Illness
por: Vargas, Maxemiliano V., et al.
Publicado: (2021)

Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico
por: Bhatt, Snehal R., et al.
Publicado: (2022)

Characterization of three naturally occurring lignans, sesamol, sesamolin, and sesamin, as potent inhibitors of human cytochrome P450 46A1: Implications for treating excitatory neurotoxicity
por: Du, Jie, et al.
Publicado: (2022)

The ethics of psychedelic research in disorders of consciousness
por: Peterson, Andrew, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ast5v2bklo61m8s6vji5o1f3s4